Similar articles

• ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.

  Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G. Angeli F, et al. Am J Cardiovasc Drugs. 2010;10(4):247-59. doi: 10.2165/11539510-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 20653331
• [Beta blockers reduce cardiac complications in patients undergoing surgery].

  Hynynen M. Hynynen M. Duodecim. 2000;116(17):1805-7. Duodecim. 2000. PMID: 12001633 Finnish. No abstract available.
• The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.

  Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C; Diabetic Postoperative Mortality and Morbidity group. Juul AB, et al. Am Heart J. 2004 Apr;147(4):677-83. doi: 10.1016/j.ahj.2003.10.030. Am Heart J. 2004. PMID: 15077084 Clinical Trial.
• Perioperative issues: myocardial ischemia and protection--beta-blockade.

  Maggio PM, Taheri PA. Maggio PM, et al. Surg Clin North Am. 2005 Dec;85(6):1091-102, viii. doi: 10.1016/j.suc.2005.09.016. Surg Clin North Am. 2005. PMID: 16326195 Review.
• Beta-blockers and risk of all-cause mortality in non-cardiac surgery.

  Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Repaci S, del Pinto M, Gentile G, Cavallini C, Reboldi G. Angeli F, et al. Ther Adv Cardiovasc Dis. 2010 Apr;4(2):109-18. doi: 10.1177/1753944710361731. Epub 2010 Mar 3. Ther Adv Cardiovasc Dis. 2010. PMID: 20200201 Review.